Literature DB >> 14576470

Modified hysteroscopic myomectomy of large submucous fibroids.

Atef Darwish1.   

Abstract

OBJECTIVE: To compare the efficacy, feasibility, operative time and possible complications of a modified technique of hysteroscopic removal of large submucus myomata versus traditional morcellation technique, and to assess the efficacy of preoperative sonohysterography (SHG).
DESIGN: A prospective comparative study.
SETTING: Gynecologic Endoscopy Unit, Assiut University Hospital, Assiut, Egypt.
SUBJECTS: One hundred forty-two women of childbearing age with a clinical and transvaginal sonographic diagnosis of large solitary submucous myomata (>3 cm in diameter) with or without an intramural element.
INTERVENTIONS: The patients were divided into two groups. In group A (65 patients), a modified resectoscopic technique was used where the base of the myoma was excised followed by ring forceps extraction after misoprostol priming. In group B (77 patients), the myoma was cut using traditional resectoscopic morcellation. MAIN OUTCOME MEASURES: For each patient, operating time, intra- and postoperative complications and feasibility of the procedure were recorded. The accuracy of preoperative SHG in localizing submucous myoma and detecting intramural extension was assessed by diagnostic hysteroscopy.
RESULTS: Transvaginal SHG showed good agreement with hysteroscopy in localizing submucous myomata and detecting intramural extension (k = 0.83). The operating time was significantly shorter in group A (15.6 +/- 3.02 min) than in group B (28.9 +/- 4.3 min). The procedure was completed in 60 (92%) and 51 patients (66%), whereas a second session was required in 2 (3%) and 20 patients (25.9%) in both groups respectively. Glycine volume was highly significantly less in group A (2.3 +/- 0.86 vs. 6.3+/- 1.7 liters, p = 0.001). Intraoperative complications were encountered in 9 (13.8%) and 22 patients (28.5%) in both groups respectively (p = 0.03). Cervical laceration was diagnosed in 3 cases (4.6%) in group A. Postoperative visual disturbances were diagnosed in 4 cases (5%) in group B.
CONCLUSIONS: Hysteroscopic resection of large submucous myomata with minimal intramural encroachment is feasible using a modified technique. It shows a minimal complication rate and fluid deficit and a shorter operative time than the standard morcellation technique. If the excised myoma is extracted as one mass, this carries a minimal risk of cervical lacerations and possible cervical incompetence in a subsequent pregnancy. Transvaginal SHG is a reliable diagnostic aid to assess submucous myomata. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14576470     DOI: 10.1159/000074451

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  4 in total

1.  The efficacy, cost and patient satisfaction of classic versus office hysteroscopy in cases with suspected intrauterine space occupying lesions with 3-dimension ultrasound and abnormal uterine bleeding.

Authors:  Tarık Filiz; Emek Doğer; Aydın Corakçı; Semih Ozeren; Eray Calışkan
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-12-01

2.  Hysteroscopic myomectomy without anesthesia.

Authors:  Nuria-Laia Rodríguez-Mias; Montserrat Cubo-Abert; Laura Gomila-Villalonga; Juanjo Gómez-Cabeza; Jose Luis Poza-Barrasús; Antonio Gil-Moreno
Journal:  Obstet Gynecol Sci       Date:  2019-04-04

3.  Likelihood of Accomplishing an In-Patient Hysteroscopic Myomectomy in a One-Step Procedure: A Systematic Review and Meta-Analysis.

Authors:  Ugo Indraccolo; Vittorio Bini; Alessandro Favilli
Journal:  Biomed Res Int       Date:  2020-01-08       Impact factor: 3.411

4.  Prediction of the operative time for hysteroscopic myomectomy for leiomyomas penetrating the intramural cavity using leiomyoma weight and clinical characteristics of patients.

Authors:  Wataru Isono; Osamu Wada-Hiraike; Ryo Sugiyama; Masanori Maruyama; Tomoyuki Fujii; Yutaka Osuga
Journal:  Reprod Med Biol       Date:  2018-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.